FiercePharma2h
Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
FiercePharma5h
Don't call it a comeback: Pfizer returns to Super Bowl with ad pledging to 'knock out' cancer
Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...
FiercePharma5h
Looking ahead at the most anticipated drug launches of 2025
If Fierce Pharma Marketing’s annual list of the top 10 biggest potential drug launches of the coming year is any indication, ...
FiercePharma23h
Will Gilead's twice-yearly injection dominate the HIV PrEP market? GSK doesn’t think so
The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...
FiercePharma22h
Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration
Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...